We are live on ! Find out more

36 hedge funds and large institutions have $10.3M invested in Imunon in 2014 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more funds holding

Funds holding: 30 → 36 (+6)

2.78% less ownership

Funds ownership: 17.69% → 14.9% (-2.8%)

20% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 10

24% less capital inflows, than outflows

Capital inflows: $643K | Capital outflows: $841K

50% less call options, than puts

Call options by funds: $3.06M | Put options by funds: $6.13M

Holders
36
Holders Change
+6
Holders Change %
+20%
% of All Funds
1.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
8
Reduced
10
Closed
–
Calls
$3.06M
Puts
$6.13M
Net Calls
-$3.07M
Net Calls Change
+$1.81M

IMNN Hedge Fund Activity: Q2 2014 in Review

36 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q2 2014, worth a combined $10.3M — up 0.67% from $10.2M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new IMNN positions and 0 closed out — a net gain of 6 holders — while 8 added to existing stakes and 10 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $187K. The largest seller was Sabby Management, cutting an estimated $250K.

  • 36 institutional investors held Imunon (IMNN) as of Q2 2014, up from 30 in Q1 2014.
  • Funds reported $10.3M of Imunon stock for Q2 2014, up 0.67% quarter-over-quarter.
  • 6 funds opened new Imunon positions in Q2 2014 and 0 closed out, a net change of +6 holders.
  • The largest Imunon buyer in Q2 2014 was Susquehanna International Group, an estimated $187K added.
  • The largest Imunon seller in Q2 2014 was Sabby Management, an estimated $250K sold.

Based on aggregated 13F filings for Q2 2014.